Tevogen Bio Holdings Inc.
TVGN
$7.00
-$2.54-26.63%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 10.99M | 15.88M | 19.95M | 20.16M | 21.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.19M | 26.14M | 30.89M | 31.25M | 34.40M |
| Operating Income | -21.19M | -26.14M | -30.89M | -31.25M | -34.40M |
| Income Before Tax | -21.35M | -26.28M | -31.04M | -31.20M | -35.36M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.35 | -26.28 | -31.04 | -31.20 | -35.36 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.35M | -26.28M | -31.04M | -31.20M | -35.36M |
| EBIT | -21.19M | -26.14M | -30.89M | -31.25M | -34.40M |
| EBITDA | -21.00M | -25.95M | -30.72M | -31.04M | -34.24M |
| EPS Basic | -6.98 | -8.63 | -10.69 | -10.93 | -11.37 |
| Normalized Basic EPS | -4.25 | -5.28 | -6.62 | -6.79 | -7.81 |
| EPS Diluted | -6.98 | -8.63 | -10.69 | -10.93 | -11.40 |
| Normalized Diluted EPS | -4.25 | -5.28 | -6.62 | -6.79 | -7.81 |
| Average Basic Shares Outstanding | 13.15M | 12.89M | 12.97M | 12.45M | 11.85M |
| Average Diluted Shares Outstanding | 13.15M | 12.89M | 12.97M | 12.45M | 11.85M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |